Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy

SIMPLE SUMMARY: Therapeutic efficacy of chemotherapy combined with immune checkpoint inhibitors as first-line therapy has been previously demonstrated in extensive-stage small cell lung cancer. However, there are no reports of any cytotoxic drug that is effective as second-line therapy in extensive-...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Tadashi, Fujimoto, Hajime, Fujiwara, Takumi, Ito, Kentaro, Fujiwara, Atsushi, Yuda, Hisamichi, Itani, Hidetoshi, Naito, Masahiro, Kodama, Shuji, Yagi, Akihiko, D’Alessandro, Valeria Fridman, Yasuma, Taro, Furuhashi, Kazuki, Saiki, Haruko, Okano, Tomohito, Tomaru, Atsushi, Tanigawa, Motoaki, D’Alessandro-Gabazza, Corina N., Gabazza, Esteban C., Yoshida, Masamichi, Hataji, Osamu, Ibata, Hidenori, Kobayashi, Tetsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406319/
https://www.ncbi.nlm.nih.gov/pubmed/36010946
http://dx.doi.org/10.3390/cancers14163953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406319/
https://www.ncbi.nlm.nih.gov/pubmed/36010946
http://dx.doi.org/10.3390/cancers14163953

Ejemplares similares